This document provides instructions for performing a thoracentesis procedure. It describes the indications, contraindications, necessary equipment, patient positioning, steps of the procedure, monitoring during the procedure, post-procedure care, potential complications, and instructions for abdominal paracentesis. The key steps are: administering local anesthesia, inserting a cannula or needle into the pleural space, draining pleural fluid for diagnostic testing or therapeutic relief of symptoms, and monitoring for complications such as pneumothorax after the procedure.
A brief presentation regarding etiology , clinical features , and management of chronic limb ischemia. It was presented by our unit at Department of surgery , Patna medical college
Deep vein thrombosis (DVT), is the formation of a blood clot in a deep vein, most commonly the legs.[2][a] Symptoms may include pain, swelling, redness, or warmth of the affected area. About half of cases have no symptoms. Complications may include pulmonary embolism, as a result of detachment of a clot which travels to the lungs, and post-thrombotic syndrome.[2][3]
Risk factors include recent surgery, cancer, trauma, lack of movement, obesity, smoking, hormonal birth control, pregnancy and the period following birth, antiphospholipid syndrome, and certain genetic conditions. Genetic factors include deficiencies of antithrombin, protein C, and protein S, and factor V Leiden mutation. The underlying mechanism typically involves some combination of decreased blood flow rate, increased tendency to clot, and injury to the blood vessel wall.
A brief presentation regarding etiology , clinical features , and management of chronic limb ischemia. It was presented by our unit at Department of surgery , Patna medical college
Deep vein thrombosis (DVT), is the formation of a blood clot in a deep vein, most commonly the legs.[2][a] Symptoms may include pain, swelling, redness, or warmth of the affected area. About half of cases have no symptoms. Complications may include pulmonary embolism, as a result of detachment of a clot which travels to the lungs, and post-thrombotic syndrome.[2][3]
Risk factors include recent surgery, cancer, trauma, lack of movement, obesity, smoking, hormonal birth control, pregnancy and the period following birth, antiphospholipid syndrome, and certain genetic conditions. Genetic factors include deficiencies of antithrombin, protein C, and protein S, and factor V Leiden mutation. The underlying mechanism typically involves some combination of decreased blood flow rate, increased tendency to clot, and injury to the blood vessel wall.
Physiotherapy in surgery in abdominal and thoracic surgeryDrKhushbooBhattPT
Rehabilitation is one of the important aspect in pre and post surgery care.
This presentation is mainly focusing on the "thoracic and abdominal rehabilitation" and also gives details about assessment and management of "intercostal drains".
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
2. PLEURAL TAP/THORACOCENTASIS
• Thoracentesis also known as thoracocentesis ,pleural tap, pleural fluid
aspiration, needle thoracotomy,
• Thoracentesis is an invasive percutaneous procedure during which a
needle/cannula is inserted into the pleural space and pleural fluid is
removed, generally after administration of local anesthesia
3. Indications-
Diagnostic-
• Unilateral pleural effusion
• Bilateral pleural effusions where aetiology unclear
• Hemo-pneumothorax
• Empyema
Therapeutic-
• Symptomatic pleural effusions/ large pleural effusion
• Failed initial medical management (diuresis, treatment of underlying cause)
4. Contraindication-
• Coagulation disorder
• Active skin infection
• Atelectasis
• Only one functioning lung
• Emphysema
• Severe cough or hiccups
• An uncooperative patient
5. Before the procedure
1.Explain the purpose, risks/benefits, and steps of the procedure
2. Obtain consent from the patient or appropriate legal design.
3. Do Diagnostic Tests such as (to determine the affected lung)
• chest x-ray
• Ultrasonography
4. Check platelet count and/or presence of coagulopathy-To
prevent complication such as bleeding during procedure
6. Prepare Equipments
• Chlorhexidine solution/ Lignocaine injection 1%
• Sterile gauze/ Sterile drape/ Sterile gloves
• 5 or 10ml syringe for anesthetic injection/ 50ml syringe for fluid removal
• 22G needle for injection of local anesthetic
• 18G cannula for thoracentesis
• 3-way tap and extension set specimen containers
7.
8.
9.
10.
11.
12. Positioning of patient
• Place patient upright position,
sitting position on edge of bed
leaning forward with his or her
arms resting on a bedside table,
pillow under arms as a comfort
measure
• To Ensures that the diaphragm is
more dependent and facilitates
the removal of fluid.
• The lateral recumbent position
• (if patient unable to sit)
13.
14. Procedure
• Written consent should be documented where possible
• Perform time out and confirm correct location for procedure, correct patient, correct procedure, correct
side
• Mark site for needle aspiration using ultrasound guidance on the postero-lateral aspect of chest wall
unless time critical and/or life saving and ultrasound unavailable (clinical marking of effusion - percuss
upper border of effusion and mark area 1-2 intercostal spaces below this)
• Ensure the proposed site is directly over a palpable intercostal space and above the level of the diaphragm
(no lower than 8th intercostal space)
15.
16.
17.
18. • Anaesthetise the epidermis overlying the superior edge of the rib that lies
below the selected intercostal space using 1% or 2% lignocaine and a 22G
needle
• Now insert that same needle perpendicular to the skin until you hit the rib
and then ‘walk’ it along the superior edge of the rib, alternately injecting
anaesthetic and pulling back on the plunger every 2 or 3mm to rule out
intravascular placement and to check for proper intrapleural placement.
19. • Once pleural fluid is aspirated, stop advancing the needle and inject additional lignocaine to anaesthetise
the highly sensitive parietal pleura. Note the depth of penetration before withdrawing the needle.
• Attach an 18G cannula to a syringe and advance the needle along in the same plane as the local
anaesthetic was injected, ensuring that you continuously pull back on the plunger
• Once you obtain pleural fluid then remove the needle leaving the cannula in place
• REMEMBER: Cover the open hub of the catheter with a finger to prevent the entry of air into the pleural
cavity
20. • Attach a 50ml syringe with a 3 way tap to the catheter hub and open the
tap to the patient and syringe to aspirate 50ml of pleural fluid for
diagnostic analysis
• Close the 3 way tap to the patient as you distribute the fluid into relevant
specimen containers
• If performing therapeutic thoracentesis, then attach the extension set to
the third port with the free end in a container to collect the pleural fluid
21. • Remove fluid in the following fashion with the syringe re-attached to the 3 way tap:
1. Open tap to patient and syringe
2. Withdraw 50ml fluid
3. Close tap to patient and ensure it is open to syringe and extension tubing
4. Empty the syringe whilst it is still attached by pushing the plunger and re-routing the fluid down the
extension set into the container
5. Repeat above steps
Do not remove more than 1500ml fluid due to risk of re-expansion oedema
When procedure is complete remove catheter with patient at end expiration (i.e. ask the patient to take
deep breath in, blow fully out and then hold their breath, then remove the cannula during the breath hold)
and cover site with an occlusive dressing
22. During the procedure
• Observe patient respiration rate and breathing pattern-R: to provide base
line data to estimate patient tolerance of procedure
• Assess patient vital sign such as B/P, pulse- To prevent any complication
such as hypovolemic shock during procedure
• Observe patient level of consciousness and give- emotional support(to
reduce patients anxiety)
• Monitor O2 saturation (to prevent hypoxia)
• Drain max 1.5 L in one sitting( to avoid Re-expansion pulmonary edema)
23. Post procedure care
• Perform a post aspiration chest x-ray- to rule out pneumothorax or
condition of lungs, fluid levels
• Provide appropriate analgesia
• Monitor for evidence of any complications: pneumothorax, post expansion
pulmonary oedema, bleeding, intra-abdominal organ injury (rare),
infection (delayed and rare)
24. After the procedure
• Document the procedure, patient’s response, characteristics of fluid and
amount, and patient response to follow-up.
• Rest in bed for about 2 hours after the procedure -To minimize patient
activity due to complication such as dyspnea.
• Blood pressure and breathing will be checked for up to a few hours
-to make sure don't have complications
25. Send fluid for:
• Cytology, MC&S, LDH, Protein
• pH (put some fluid in an ABG syringe and run through the ABG machine if
necessary)
• Consider TB culture (acid-fast bacilli)/ gene x-pert if clinically indicated
• Consider glucose or cholesterol (if concerned about chylothorax)
• Send serum blood samples for LDH and protein.
28. Abdominal paracentasis/Ascitic Tap
• Abdominal paracentesis is a bed side clinical procedure in which needle is
inserted into peritoneal cavity and ascitic fluid is removed.
• TYPES:-Diagnostic: New onset ascites (etiology) or possibility of SBP in
patient with ascites
• Therapeutic: Symptomatic tense ascites with cardiorespiratory or
gastrointestinal symptoms
29. Indications
• For evaluation of new onset ascites.
• Testing of ascitic fluid.
• For evaluation of pt. with ascitis who has signs of clinical deterioration like
fever, abd.pain, hepatic encephalopathy, decreased renal function n
metabolic acidosis.
• Paracentesis can identify unexpected diagnosis such as chylous,
hemorrhagic or esinophilic ascites useful to know etiology n antibiotic
susceptibility.
30. Contraindications
• Absolute-overlying site infection
• Relative- coagulopathy (INR>1.5, Plt<50) although routine INR and FBC not
indicated prior to procedure and replacement only if signs of bleeding;
• Anatomical – adhesions, neuropathic bladder, suggest US prior to needle insertion
to identify areas of anatomical concern.
• Massive ileus with bowel distension.
• Near the surgical scar because scars are asso. With tethering of bowel to abd.wall
n will cause bowel perforation.
• Shock
31. • Abnormal coagulation studies like increased INR n Thrombocytopenia are
not contraindications.
• 70% pts with Ascites have abnormal PT but risk of bleeding is low.
• Pt who bleed had renal failure suggesting qualitative platelet dysfunction
asso. With renal failure. Here desmopressin may be used before
paracentesis in pts with cirrhosis and renal failure.
32. Patient preparation-
• Explain the procedure & Obtain Consent
• No fasting before Procedure
EQUIPMENT & STAFF
• Clinician & Assistant
• Bottles should be labelled for tests prior doing paracentesis
• Bacterial culture is done in pts with SBP
33. Choice of needles-
• DIAGNOSTIC: 1.5 Inch, 22 Gauge needle For Obese :3.5 Inch, 22 Gauge
spinal needle
• THERAPEUTIC: 15/ 16 Gauge needle to speed up the removal
Position of patient-
Supine posture ,head may be elevated 30degree,
Knee elbow position for removal of minimal fluid in dependent area
34. EQUIPMENTS
• PPE – sterile gloves
• Antiseptic
• Local anaesthetic - lignocaine+/-adrenaline 1% 10mls
• Paracentesis kit - drape, syringe for local(5mls), syringe for sample(20mls), needle for LA
injection (25G or 23G)
• Sample collection – EDTA tube, blood culture bottles, urine container
• Leur lock drainage bag
• 12F Dwellcath needle
• 20% albumin if LVP planned
35. Site-
• Lt lower Quadrant (Dullness on percussion)
• 3cm medial & 2cm above the ant. Sup. Iliac spine
• Not near umbilicus because of presence of collateral vessels
• Surgical scars & visible veins should be avoided.
36.
37. WHY LEFT???
• Abd. Wall is thinner.
• Pool of fluid is more.
• Pt can be rolled easily to left for drainage
WHY NOT RIGHT???
• Appendicectomy scar, caecum filled with gas in pts taking lactulose.
• Care must be taken not to injure inferior epigastic artery which bleeds
massively & which is located near pubic tubercle
38. SKIN STERLISATION
• Mark the site as “X” &
positions 12, 3, 6, 9 a few
centimeters from “X”
• Sterilise with Iodine or
Chlorhexidine Solution
starting from X using
widening circular motions.
39. LOCAL ANESTHESIA
• Anaesthetise using 3- 5 ml of 1% Lignocaine Solution in a “Z” track
technique.
• Needle used for it is 1.5inch which is sufficiently long.
• Choose the site & pass the needle tangentially, raising a wheal with
Lignocaine.
• “Z” track creates a non linear pathway b/n Skin& Ascitic fluid & minimise
the chance of leakage.
40.
41. • With one hand pull the abdominal wall n with other hand operate the syringe.
Hand on the abd.wall should not be removed untill the needle enters the fluid.
• Insert the needle n syringe 5mm deep
• pull the plunger back with each advancement to see if any blood is aspirated.
• then inject the lignocaine sol.
• Cont. the same procedure until the needle enters fluid.
42. • Aspiration should be intermittent not continuous.
• Cont. may pull the bowel or omentum onto needle tip,occluding the tip.
• Yellow color fluid indicates needle is in the peritoneal cavity.
• NEEDLE INSERTION:
• Needle is inserted along anesthetised pathway after nick is given with 11
no. blade. Fliud should drip from the hub of the needle.
• Larger the nick greater the post paracentesis leak.
43. • Ultrasound guidance can be used to guide the procedure.
• During laproscopy parietal peritoneum may form tenting over needle n fluid doesn’t come.
• Operator cant see this n may mis interpret as DRY TAP.
• Rotating the needle for 90 degrees or more will pierce the peritoneum n help the drainage.
• Small amount of fluid may be difficult to drain bcoz omentum/bowel may block the end of needle. So
multi hole needles are helpful.
• Misconception of poor flow is LOCULATION.
• True loculation is seen in peritoneal carcinomatosis with malignant adhesions or bowel rupture with
surgical peritonitis.
• Loculation never occur in cirrhosis or heart failure with ascites or SBP.
44. • Stable needle n depth of penetration of needle are crucial for successful
paracentesis.
TESTING- 25 ml fluid is enough for cell count,diff count,chemical testing n
bacterial culture.
In TB 50ml for cytology
50ml for smear n culture
45. LARGE VOLUME PARACENTASIS
• It is removal of >5 lit of fluid.
• In refractory ascites,removal of as much fluid as possible with
sod.restricted diet n diuretics will extend the interval to next paracentesis.
• REMOVAL OF NEEDLE:
• Needle is removed with one rapid smooth withdrawal motion.
• Distract the pt by asking him to cough bcoz cough will prevent pain
sensation
46. Tips and tricks
• Check (fluid amount and adhesions) the insertion point with USG prior to
commencement with patient in position
• Dot advance the cannula once filed non-sterile
• Use the Z-line insertion technique to decrease leakage
47. Complications
Common
Local- Leakage of ascitic fluid(single suture)
Haematoma
Systemic- Post paracentesis circulatory dysfunction(PCD) following LVP(large volume paracentesis >5L)
• Uncommon
secondary bacterial peritonitis-Infection (local or intraperitoneal) rare<0.2%
• Bowel perforation - rare with US
• Vessel perforation - mitigated by point of entry
49. Lumbar puncture
• Diagnostic lumbar puncture is the insertion of a hollow needle into the
subarachnoid space of the spinal canal for collection of cerebrospinal fluid
(CSF). The procedure may include measurement of CSF pressure; however
this measurement is not routine in every Emergency Department.
• LP is considered an invasive procedure, and where possible, written
consent should be sought from the patient.
50. Indication
Emergency Department indications are clinical suspicion of:
• CNS infection (meningitis, encephalitis)
• Subarachnoid Haemorrhage (SAH)
Contraindications
• Skin infection surrounding the site
• Evidence of raised intracranial pressure
• Platelet count less than 50 ×10^9/L
• INR >1.5
• Unfractionated Heparin or LMWH in the past 24 hours
• Known coagulopathy e.g. Haemophila, von Willebrand disease
• Trauma to lumbar vertebrae
• Unstable patient/ALOC
51. Equipments
• A standard kit might contain:
• Sterile gloves
• Chlorhexidine 2%, cotton balls and forceps
• Drape
• Lignocaine 1%, 23g needle, syringe
• Spinal needle (see below)
• Pressure measuring tube and three way tap (see below)
• 3 or 4 collection tubes
52.
53. Patient positioning
• The spinal cord ends at L1/L2 level in adults.
• Place one hand on each ASIS and move medially to the midline, locating the spine. This is
L4 and LP may be performed through the 2 spaces above (L3/L4 or L2/L3) or one space
below (L4/L5).
• LP can be performed with the patient either lying down or sitting up. Choose the position
that you and the patient are most comfortable with.
• Optimise patient position to increase the interspinous distance as much as possible: flex
the spine and hips.
• Perform LP on infants and unconscious patients, with the patient lying down, and an
assistant maintaining spinal flexion.
54. Lying down
• Patient should be lying in the lateral decubitus position.
• Ensure the vertical plane of the patients back is
perpendicular to the bed.
• Flex knees and hips so that knees are close to the chest.
• While flexion of the neck is often taught as important,
evidence suggests that this has no effect of the size of
the interspinous opening and may be uncomfortable for
the patient.
• Postioning correctly is all about increasing the
interspinous distance as much as possible.
55.
56. Sitting-
• This position generally makes it easier to identify anatomical landmarks and
planes.
• Sit the patient on a firm surface.
• Patient should lean forward, and can hug a pillow on a table at the right height to
flex (not extend) the back.
• Lift the patient’s legs by putting their feet on a stool or chair and flex the hips to
above 90 degrees.
• If pressure measuring is required, lie the patient on their side (after successful
needle insertion) with assistance and then open the tap to measure the pressure.
57.
58. Preparation
• Wash hands and use sterile gloves.
• Prepare the skin with povidone-iodine or chlorhexidine.
• Apply sterile drape(s).
• Uncap specimen tubes.
• Infiltrate skin with local anaesthetic.
• Use introducer needle on syringe with LA, insert in the plane for the LP
• Aim in between spinous processes, towards the umbilicus (ie slightly cephalad).
• Inject LA as you go, remove syringe and leave introducer needle in situ.
59. puncture
• Use the spinal needle (with stylet in) to pierce the skin ( or where you have used an introducer needle
insert) over the selected interspinous space in the midline.
• Aim in between spinous processes, towards the umbilicus (ie slightly cephalad).
• As the needle passes through the interspinous ligament, there is likely to be increased resistance.
• Advance the needle through the ligament until there is a decrease in resistance. The needle tip is now
likely to be near or within the subarachnoid space.
• In a 70 kg male the ligamentum flavum sits at around 4.5 cm, use this distance or a measured distance
from ultrasound.
• Remove the stylet to check for CSF.If there is no flow of CSF, replace the stylet and advance the needle
slightly before checking again for CSF.
60. Cont.
• Alternatively, remove the stylet once the needle is in the interspinous ligament and advance the open
needle slowly, watching for flow of CSF.
• If the needle meets hard (bony) resistance, withdraw the open needle slowly, watching for flow of CSF. If
there is no flow once the needle tip has backed into the ligament, try advancing in a different direction
using either technique.
• When there is reliable flow of CSF, attach a 3-way-tap if measuring pressures, or collect a sample directly
into the specimen containers.
• Collect 10 to 20 drops (5 to 10 for children) in each container, keeping track of the order in which
containers are filled (they may already be numbered).
• After collection, replace the stylet and remove the needle and stylet together.
• Apply a sterile dressing to the puncture site.
61. COMPLICATIONS
• Failure to obtain CSF
• Post-lumbar-puncture headache (increased risk with:
large bore needle; cutting needle; multiple attempt;
excessive CSF removal; dehydration; female patient)
• Epidural haematoma / local haemorrhage
• Epidural abscess
• Transtentorial herniation (view the video 'Lumbar
Puncture Procedure and Interpretation' to see a
discussion on whether this is the risk we think it is)
• Back pain
63. Definition-
• Intravenous (IV) Cannulation Is a technique in which a cannula is placed
inside a vein to provide venous access
PURPOSES-
To administer intravenous injection
To administer intravenous fluids.
To administer radiological contrast agent prior to CT/MRI
Blood sampling/ transfusion of blood and blood products, chemotherapy
64. Equipments-
Articles A tray containing :
• Sterile gloves
• Iv cannula
• Tourniquet
• Cotton swabs
• Adhesive tape
• Spirit
• I.V. stand ,I.V. set
70. Why veins are suitable for iv cannulation ?
• Superficial
• Palpable
• Visible
• Blood flow at low pressure
• Relatively large internal diameter
• Tough vascular wall-able to form seal around cannula
• Offer rapid route to systemic circulation
• Many choices remote from sensitive structures.
71. Point to remember while selecting the vein
• Make use of the most distal part of the vein
• Avoid puncturing the vein on joint . It will hinder the normal movement of
joint
• Avoid puncturing the vein in close proximity to an infected wound
• Avoid puncturing the vein on extremity having a shunt
• Try avoid puncturing the vein of lower extremities in adults . Because of
the high risk of development of deep vein thrombosis
72.
73.
74.
75. Procedure-
• To start an Iv , first prepare all of equipment . This will include the IV bag , with
containing tubing , with all air flushed out of tubing
• Place a tourniquet around the arm . This should be tight enough to block venous
blood flow back to the heart , but not so tight that it obstructs the arterial flow
• Wait long enough for the veins in the hands & arm to fill & become tight . In a
normal person , this may take 2-5 minutes .In a dehydrated person or someone in
shock , it may take longer
• Cleanse the skin of injection site with spirit cotton balls . If spirit is not available ,
use any antiseptic or skin cleanser
76.
77.
78. Continue-
• Use your left thumb to hold the vein in place while you insert the IV needle at a
shallow angle ( about a 20 degree angle ) through the skin & into the vein
• As you enter the vein , you will feel a slight “pop”. You will know you are in the
vein when you see blood returning in the “flash back “ chamber
• Keep the needle in place with one hand while you push the catheter (which
surrounds the needle ) further into the vein . This will thread it upstream ,
securing it into the vein
• Once that catheter is completely inserted , hold it in place with one hand while
you release the tourniquet & pull the needle straight out with the other hand
79.
80. Procedure continue-
• Pressing down the skin where the catheter tip is located will prevent blood from
flowing back out the IV catheter before you have a chance to connect the IV
tubing's
• Connect the IV tubing's & run In the IV fluids briskly , at first . Then slow it down
to a steady drip
• If the fluid does not flow freely at the beginning, check the IV tubing's to see if
there are any valves or other obstruction to flow .If the tubing is wide open , but
the IV is dripping only very slowly , you are probably not in vein.
• Try again -Observe the site the edema , swelling , redness. After administering IV
fluids , flush the I.V. line with NS & lock it with stopper
86. Vein finders
• A Vein Finder
• Is exactly what it sounds like, It is a device that is used to reduce the
amount of time it takes to find a vein on a patient
• How Do Vein Finders Work? An infrared vein finder uses a specific type of
light, which is able to penetrate the skin by a
• few millimetres to illuminate the targeted veins
• Other types of vein finders, usually in the form of glasses, which work by
altering the color of the light visible to the eye
87.
88. Complications of IV cannulation
• Thrombophlebitis
• Local and systemic infection
• Bleeding/ injury to artery
• Extravasation
• Air embolism